Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Intezyne Technologies is dedicated to treating cancer better. Intezyne's nanotechnology platform, the IVECT Method, can be generated around a broad array of drugs, from small molecules to peptides/proteins to nucleic acids, making the platform highly...Show all
Company (Alive / Active)
Phone: 813-910-2120
3720 Spectrum Blvd
Suite 104
Tampa, 33612
Florida, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Use of trans-[tetrachlorobis(1h-indazole)ruthenate(iii)] for the treatment of cancer | Mar 01, 2017 | Nov 03, 2020 | Patent |
Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof | May 07, 2018 | Apr 07, 2020 | Patent |
Melanocortin 1 receptor ligands and methods of use | Sep 12, 2016 | Jun 25, 2019 | Patent |
Sn-38 loaded iron crosslinked micelle and methods thereof | Feb 08, 2018 | Dec 04, 2018 | Patent |
Block copolymers for stable micelles | Sep 28, 2016 | Aug 14, 2018 | Patent |